PERTUSSIS IMMUNISATION
Clinical trials for PERTUSSIS IMMUNISATION explained in plain language.
Never miss a new study
Get alerted when new PERTUSSIS IMMUNISATION trials appear
Sign up with your email to follow new studies for PERTUSSIS IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 6-in-1 shot for babies shows promise in thai trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new combination vaccine called Shan6™, which protects against six diseases (diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio) in healthy infants and toddlers in Thailand. The trial involved 460 participants and compared Shan6™ to a similar 5-in…
Matched conditions: PERTUSSIS IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:51 UTC
-
New pneumonia vaccine shows promise in toddlers and infants
⭐️ VACCINE ⭐️ CompletedThis completed Phase 2 trial tested three new formulations of a pneumococcal conjugate vaccine (SP0202) in 852 healthy toddlers and infants. The goal was to see if these vaccines are safe and produce a strong immune response when given alongside routine childhood vaccines. Resear…
Matched conditions: PERTUSSIS IMMUNISATION
Phase: PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 15:05 UTC
-
Pertussis booster study: does your first vaccine matter?
Knowledge-focused CompletedThis study in South Africa looked at 273 children who received a Tdap-IPV booster vaccine. Researchers wanted to see if the type of pertussis vaccine they got as babies affected their immune response. The study measured antibodies and cell-mediated immunity over time.
Matched conditions: PERTUSSIS IMMUNISATION
Phase: PHASE4 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:25 UTC